Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
Clinical trial NCT03991780 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03991780
- Sponsor
- Imperial College London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2023-04-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.